SAN FRANCISCO – Dr. Yvonne A. Efebera and Dr. Nina Shah debate whether patients with multiple myeloma should receive maintenance until progression...
Outcomes Research in Review
Dr. Richard L. Schilsky, chief medical officer at ASCO, tackles the issue of how to determine the value of cancer drugs.
Approximately two-thirds of patients with distant progression had one or two new lesions.
Allowing any radiologist, rather than a lead radiologist, to establish CT protocols is associated with high likelihood of exceeding ACR dose...
Two HIV-positive patients with chemotherapy-refractory, high-grade B-cell lymphoma achieved complete remission with anti-CD19 CAR T-cell therapy,...
In a review of trials and postmarket safety databases, the FDA found there were reports of serious cases of pneumonitis, including fatalities,...
If your patient expresses interest in medical marijuana, you’ll find evidence on maximizing benefit while minimizing risk. But be cautious: Data...
The USPSTF finds minimal value in medications to help prevent breast cancer for women not at increased risk